Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters Lidija TodorovićBoban StanojevićShunichi Yamashita Original Paper 16 January 2018 Article: 17
Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma Kazuhiro YamamotoIkuko Yano Review Article 04 January 2018 Article: 16
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas Roberto CastelliLuigi BergamaschiniGiorgio Lambertenghi Deliliers Short Communication 29 December 2017 Article: 15